We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
48 hedge funds and large institutions have $139M invested in Zevra Therapeutics in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
45% more funds holding
Funds holding: 33 → 48 (+15)
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
33% more capital invested
Capital invested by funds: $104M → $139M (+$34.7M)
Holders
48
Holders Change
+15
Holders Change %
+45.45%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
19
Increased
13
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$16.7M |
| 2 |
DA
DSC Advisors
Chicago,
Illinois
|
+$2.99M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.88M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.68M |
| 5 |
Goldman Sachs
New York
|
+$1.06M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$1.14M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$1.14M |
| 3 |
Millennium Management
New York
|
-$629K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$404K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$347K |
